What are the next steps for a female patient of reproductive age who stopped birth control (hormonal contraception) and has not experienced menstruation (amenorrhea) despite a negative pregnancy test, and desires to become pregnant?

Post-Contraception Amenorrhea with Negative Pregnancy Test in a Patient Desiring Pregnancy

For a patient with amenorrhea after stopping hormonal contraception who has a negative pregnancy test and desires pregnancy, you should first confirm she is truly not pregnant, then provide preconception counseling and fertility optimization advice, and if amenorrhea persists beyond 6 months post-contraception, initiate evaluation and consider ovulation induction with clomiphene citrate. 1

Immediate Assessment

Confirm pregnancy status is truly negative:

• A negative urine pregnancy test has 99-100% negative predictive value when the patient meets specific criteria (no unprotected intercourse in past 5 days, proper timing since last menstrual period) 2
• However, a negative pregnancy test in the setting of amenorrhea with unknown last menstrual period does not definitively rule out pregnancy and warrants close follow-up 3
• If there has been recent unprotected intercourse (within 5 days), the test may be falsely negative and should be repeated in 2-4 weeks 2

Post-Pill Amenorrhea Context

Post-contraception amenorrhea is defined as failure to resume menstruation within 6 months after discontinuing hormonal contraceptives 1:

• This typically presents with a pattern of hypothalamic deficiency: low gonadotropins, low ovarian hormones, and mild-to-moderate prolactin elevation 1
• Most cases are relatively uncomplicated but require exclusion of pituitary tumors or serious endocrine abnormalities before treatment 1
• In many cases, spontaneous return of menstruation occurs without intervention 1

Preconception Counseling (Initiate Immediately)

All patients desiring pregnancy should receive comprehensive preconception counseling regardless of menstrual status 4:

• Folic acid supplementation: Start immediately at 400-800 mcg daily to reduce neural tube defect risk 4
• Optimize chronic medical conditions: Diabetes, hypertension, thyroid disease, psychiatric illness should be optimally managed before conception 4
• Lifestyle modifications: Screen for and counsel about alcohol, tobacco, recreational drugs, and prescription opioid misuse 4
• STI screening: Assess need for sexually transmitted infection testing 4
• Genetic screening: Offer screening for genetic conditions as recommended for pregnant women 4
• Intimate partner violence screening: Routinely assess for safety concerns 4

Fertility Optimization While Awaiting Menses Return

Provide specific fertility-maximizing strategies 5:

• Timing of intercourse: Advise vaginal intercourse every 1-2 days beginning soon after any menstrual bleeding ends 5
• Ovulation detection: Discuss methods to identify fertile days including cervical mucus monitoring (slippery, stretchy quality indicates the 6-day fertile window ending on ovulation day), over-the-counter ovulation predictor kits, digital applications, or cycle beads 5
• Weight optimization: Fertility rates are lower in women who are very thin or obese 5
• Caffeine reduction: Limit to less than 5 cups per day 5
• Avoid fertility-reducing factors: Discourage smoking, alcohol consumption, recreational drugs, and most commercial vaginal lubricants 5

Timeline for Intervention

The critical decision point is 6 months post-contraception cessation 1:

• Before 6 months: Reassurance and expectant management with periodic follow-up is appropriate, as spontaneous return of menstruation is common 1
• At or beyond 6 months: Active evaluation and treatment are indicated if pregnancy is desired 1

Evaluation at 6 Months (If Amenorrhea Persists)

Before initiating treatment, exclude serious pathology 1, 6:

• Pituitary evaluation: Rule out pituitary tumors (prolactin level, consider imaging if prolactin elevated) 1, 6
• Endocrine assessment: Check thyroid function, assess for adrenal disorders, evaluate for hyperprolactinemia 7, 6
• Ovarian function: Assess gonadotropin levels (FSH, LH) to distinguish hypothalamic/pituitary causes from ovarian failure 6
• Anatomical evaluation: Pelvic examination to exclude ovarian cysts, uterine abnormalities, or other structural issues 7, 6
• Progesterone withdrawal test: Administer progesterone to assess endogenous estrogen levels; bleeding indicates adequate estrogen and patent outflow tract 6, 1
• Male factor: Evaluate partner's fertility status 7

Treatment for Ovulation Induction

If evaluation confirms ovulatory dysfunction without contraindications, clomiphene citrate is first-line therapy 7, 1:

Clomiphene Citrate Protocol

• Starting dose: 50 mg daily for 5 days, beginning on cycle day 5 (if spontaneous or progestin-induced bleeding occurs) 7
• If no spontaneous bleeding: Can start at any time after confirming non-pregnancy 7
• Timing of intercourse: Coitus should be timed for 5-10 days after completing the 5-day course, when ovulation typically occurs 7
• Dose escalation: If no ovulation after first course, increase to 100 mg daily for 5 days in subsequent cycle (may start as early as 30 days after previous course) 7
• Maximum recommended: Do not exceed 100 mg/day for 5 days 7
• Duration limits: If ovulation does not occur after 3 courses, discontinue clomiphene and reevaluate; if 3 ovulatory responses occur without pregnancy, further treatment is not recommended; total therapy should not exceed approximately 6 cycles 7

Alternative: Bromocriptine

• Indicated if: Hyperprolactinemia is present 1
• Can be safely administered by family physicians experienced in its use 1

Monitoring During Treatment

• Ovulation confirmation: Use basal body temperature charting or other appropriate tests to determine if ovulation occurred 7
• Pelvic examination: Required before first and each subsequent treatment cycle to exclude ovarian enlargement or cyst formation 7
• Pregnancy testing: If menses does not occur after an ovulatory response, reevaluate for pregnancy 7

Important Caveats

Contraindications to clomiphene citrate 7:

• Current pregnancy
• Ovarian cysts (except polycystic ovary syndrome)
• Abnormal vaginal bleeding (must exclude neoplasia first)
• Liver dysfunction
• Uterine fibroids (use with caution due to potential enlargement)

Post-pill amenorrhea patients are good candidates for clomiphene therapy 7, 6:

• Patients with "post-oral-contraceptive amenorrhea" are specifically listed as likely to achieve success with clomiphene 7
• However, normogonadotrophic amenorrhea (which includes many post-pill cases) may have less favorable response compared to other causes 6

If patient does not desire immediate pregnancy:

• Reassurance and periodic follow-up with progesterone withdrawal testing is appropriate 1
• Expectation of spontaneous return of menstruation is reasonable 1